Nifedipine and Tetrodotoxin Delay the Onset of Methylmercury-Induced Increase in (Ca 2+ ) i in Ng108-15 Cells

Nifedipine and Tetrodotoxin Delay the Onset of Methylmercury-Induced Increase in (Ca 2+ ) i in... Methylmercury (MeHg) causes a multiphasic disruption of intraneuronal cation regulation. Release of Ca 2+ from internal stores and entry of extracellular Ca 2+ (Ca 2+ e ) contribute to the temporally distinct early (first Ca 2+ phase) and late (second Ca 2+ phase) components of increased intracellular Ca 2+ concentration ((Ca 2+ ) i ). The present study was designed to explore the mechanisms mediating the second Ca 2+ phase. Fluorescence intensity was monitored from single NG108-15 cells loaded with fura-2 before and during acute application of 2 μM MeHg. Nifedipine (1 or 10 μM but not 0.1 μM) significantly delayed the time-to-onset of the second Ca 2+ phase. Nifedipine (1 μM but not 0.1 μM) also caused a concentration-dependent delay in the onset of both the first Ca 2+ phase which is independent of Ca 2+ e and the elevation of non-Ca 2+ cation (non-Ca 2+ phase). The L-type dihydropyridine (DHP) Ca 2+ channel agonist Bay K-8644 (10 nM) had no effect on the time-to-onset of the second Ca 2+ phase. Neither the N-type Ca 2+ channel blocker ω-conotoxin GVIA (up to 1 μM) nor the nonselective Ca 2+ channel blocker Ni 2+ (1 mM) altered the time-to-onset of the second Ca 2+ phase. Removal of Na + e or addition of the voltage-dependent Na + channel antagonist tetrodotoxin (TTX, 1 μM) significantly delayed the onset of the second Ca 2+ phase. In a manner similar to that for 1 μM nifedipine, TTX also delayed the onset of the other phases. Thus, we hypothesize that MeHg depolarizes the plasma membrane leading to an increase in the activation of voltage-dependent Na + and Ca 2+ channels which promotes, directly or indirectly, the influx of Ca 2+ during the second Ca 2+ phase. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Toxicology and Applied Pharmacology Elsevier

Nifedipine and Tetrodotoxin Delay the Onset of Methylmercury-Induced Increase in (Ca 2+ ) i in Ng108-15 Cells

Loading next page...
 
/lp/elsevier/nifedipine-and-tetrodotoxin-delay-the-onset-of-methylmercury-induced-Nde1EU107h
Publisher
Elsevier
Copyright
Copyright © 1995 Academic Press
ISSN
0041-008x
D.O.I.
10.1006/taap.1995.1236
Publisher site
See Article on Publisher Site

Abstract

Methylmercury (MeHg) causes a multiphasic disruption of intraneuronal cation regulation. Release of Ca 2+ from internal stores and entry of extracellular Ca 2+ (Ca 2+ e ) contribute to the temporally distinct early (first Ca 2+ phase) and late (second Ca 2+ phase) components of increased intracellular Ca 2+ concentration ((Ca 2+ ) i ). The present study was designed to explore the mechanisms mediating the second Ca 2+ phase. Fluorescence intensity was monitored from single NG108-15 cells loaded with fura-2 before and during acute application of 2 μM MeHg. Nifedipine (1 or 10 μM but not 0.1 μM) significantly delayed the time-to-onset of the second Ca 2+ phase. Nifedipine (1 μM but not 0.1 μM) also caused a concentration-dependent delay in the onset of both the first Ca 2+ phase which is independent of Ca 2+ e and the elevation of non-Ca 2+ cation (non-Ca 2+ phase). The L-type dihydropyridine (DHP) Ca 2+ channel agonist Bay K-8644 (10 nM) had no effect on the time-to-onset of the second Ca 2+ phase. Neither the N-type Ca 2+ channel blocker ω-conotoxin GVIA (up to 1 μM) nor the nonselective Ca 2+ channel blocker Ni 2+ (1 mM) altered the time-to-onset of the second Ca 2+ phase. Removal of Na + e or addition of the voltage-dependent Na + channel antagonist tetrodotoxin (TTX, 1 μM) significantly delayed the onset of the second Ca 2+ phase. In a manner similar to that for 1 μM nifedipine, TTX also delayed the onset of the other phases. Thus, we hypothesize that MeHg depolarizes the plasma membrane leading to an increase in the activation of voltage-dependent Na + and Ca 2+ channels which promotes, directly or indirectly, the influx of Ca 2+ during the second Ca 2+ phase.

Journal

Toxicology and Applied PharmacologyElsevier

Published: Dec 1, 1995

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off